Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome

Launched by CASE WESTERN RESERVE UNIVERSITY · Oct 23, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called amniotic membrane therapy for women who suffer from interstitial cystitis/painful bladder syndrome (IC/PBS). This condition causes persistent bladder and pelvic pain, along with a frequent and urgent need to urinate. The main goal of the study is to see if this new therapy can significantly improve the symptoms experienced by patients, as measured by questionnaires designed to assess their condition.

To participate in this trial, women must be at least 18 years old, speak English, and have been diagnosed with IC/PBS. They should also have tried at least one other treatment that did not work for them. Unfortunately, women under 18, those who cannot give consent, or those with specific bladder or urinary tract issues cannot join. While the trial is not yet recruiting participants, if you are eligible, you may have the chance to try a new treatment that could help relieve your symptoms.

Gender

Female

Eligibility criteria

• Inclusion Criteria:
• • Patients 18 years of age or older
• • Female
• • English Speaking
• • Diagnosis of IC/PBS
• • Have failed at least one prior treatment for IC/PBS
• Exclusion Criteria:
• • Patients less than 18 years of age
• • Unable to provide consent
• • Non-English speaking
• • Patients with known anatomical malformations of the ureters, bladder, or urethra